期刊
CURRENT DRUG DELIVERY
卷 8, 期 1, 页码 70-78出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156720111793663589
关键词
Imaging technology; immunoPET; monoclonal antibodies; radiolabeling; receptor targeted therapy; THIOMAB; trastuzumab
ImmunoPET is a non-invasive imaging technology based on tracking and quantification of radiolabeled monoclonal antibodies, antibody fragments and peptides in vivo. The knowledge of distribution and expression levels of a given receptor is a key for successful receptor targeted cancer therapy. ImmunoPET performed with probes with high affinity and specificity to a given receptor aspires to be a method for obtaining comprehensive information about current in vivo status of the targeted receptor. This review describes methods for radiolabeling of peptides, monoclonal antibodies, and antibody fragments for immunoPET and highlights the recently reported pre-clinical and clinical applications of immunoPET in receptor targeted therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据